Affinity Biosensors
Developer of rapid antimicrobial susceptibility testing devices for life sciences. The company provides LifeScale, a rapid antimicrobial susceptibility testing technology that offers population-profiling for Gram-negative bacteria in positive blood culture. It also offers primary and secondary antibodies, peptides, reagent kits, inhibitors, and other related products. Founded in 2006, headquartered in Santa Barbara,…
Funding snapshot
About
Developer of rapid antimicrobial susceptibility testing devices for life sciences. The company provides LifeScale, a rapid antimicrobial susceptibility testing technology that offers population-profiling for Gram-negative bacteria in positive blood culture. It also offers primary and secondary antibodies, peptides, reagent kits, inhibitors, and other related products. Founded in 2006, headquartered in Santa Barbara, United States. The company has raised $51.8M in funding at the series b stage. T The company operates in Life Sciences > Genomics, Life Sciences > Clinical Genomics, Life Sciences > Infectious Diseases, Sustainability Tech > Infectious Diseases. Its business models include Infectious Diseases > In Vitro Diagnostic Tests > Bacterial, Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Microbial Testing > Infectious Diseases. Founded in 2006. Headquartered in United States, Santa Barbara. The company has raised funding at the Series B stage. Backed by investors including National Science Foundation.
Business model
Infectious Diseases > In Vitro Diagnostic Tests > Bacterial,
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Microbial Testing > Infectious Diseases
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.